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IT HAS BEEN SHOWN that in (A x CBA/
T6)F1 mice the presence of an F1 tumour
inhibits the graft-versus-host reaction
(GvHR) induced by injection of A strain
spleen cells (Whitmarsh-Everiss & Symes,
1981). This conclusion was based on the
finding that the presence of a tumour
significantly reduced the increase in spleen
weight produced by injection of parent-
line cells. It seemed relevant to extend
these findings by studying the effect of
tumour resection on susceptibility to
GvHR. Also, Howard (1961) found that
macrophage reactivity is increased in
mice undergoing GvHR, and activated
macrophages show increased sensitivity
to lipopolysaccharide (LPS) as judged by
a rise in plasma enzyme levels after endo-
toxin administration (Howard, 1969;
Shands & Senterfitt, 1972; Ferluga &
Allison, 1978). It thus seemed possible
to use changes in enzyme levels following
endotoxin administration to confirm our
hypothesis that the presence of a tumour
protects against GvHR. Macrophage acti-
vation in GvHR is maximal in the liver
(Howard, 1961) and hence it is predictable
that the liver-specific enzyme ornithine
carbarmoyl transferase (OCT) would be
a reliable indicator of tissue damage by
GvHR.
Groups of (A x CBA/T6)F1 mice re-
ceived an s.c. transplant of 106 F1 viable
mammary tumour cells on Day 0. In
some groups the tumour was resected,
as completely as possible, on Day 20.
One day later, halfthe animals from which
the tumour was excised, and half the ani
mals which retained their tumours, re-
ceived 108 A-strain spleen cells (immune
to F1 tumour) i.v. Additionally, F1 mice
did not receive tumour transplants, and
half of these received A spleen cells on
Day 21.
Thus each experiment contained the
following groups of mice: (i) (A x CBA)F1
with no tumour; (ii) F1 mice with an Fl
tumour; (iii) F1 mice from which the
tumour was resected on Day 20; (iv) F1
mice with no tumour receiving A spleen
cells on Day 21; (v) F1 mice with an F1
tumour receiving A spleen cells on Day
21; (vi) F1 mice, from which an F1 tumour
was resected, receiving A spleen cells on
Day 21.
Five experiments were performed. In
Expts 1-3, the mice were killed on Days
28-30 by exsanguination. Their body and
spleen weights were determined for calcu-
lation of spleen ratios and indices.
The mice in Expts 4 and 5 each received
an i.v. injection of 25 ,ug lipopolysac-
charide endotoxin (LPS) (from E. coli
strain 0 11B41 Difco) on Day 27, one
day before exsanguination to obtain
plasma for determination of OCT. In
these 2 experiments a further 2 groups
of mice were present as controls: i.e. F1
mice not receiving LPS; F1 mice injected
with A strain cells, but not receiving LPS.
A sample of plasma was also obtained
from each mouse in Expts 1 and 2 forPROTECTION AGAINST GvHR BY F1 TUMOUR
the determination ofOCT levels in animals
not challenged with LPS.
Expts 2 and 4 were commenced on the
same day, and therefore the same tumour
and A spleen cell suspensions were used.
F1 mice where the A parent is female
develop spontaneous mammary carcino-
mas. These tumours may be passaged
serially in isogenic hosts.
Tumour-cell suspensions were prepared
by the method of Milas et al. (1974).
The F1 mice used as recipients oftumour
transplants and A-strain cells were females
aged 2-3 months.
The A mice which acted as spleen-cell
donors were females aged 1-2 months.
They had been immunized by transplanta-
tion of the appropriate F1 tumour, 9 days
beforehand.
The spleen ratio of each mouse was
defined as wt of spleen (mg)/wt of mouse
(g). The spleen index was obtained by
dividing the spleen ratio of a particular
mouse by the mean spleen ratio of the
mice in the appropriate control group;
e.g. spleen ratio of individual mouse
undergoing a GvHR from which the
tumour was resected divided by mean
spleen ratio of mice in group from which
tumour was resected only (no spleen cells
injected). For an example of the calcula-
tions involved see Whitmarsh-Everiss
& Symes (1981).
The total data for a given parameter
was pooled and subjected to a one-way
analysis of variance. The significance
of individual differences was then found
by using a common variance (based on
the residual sum of squares) to calculate t.
In Expt 1 (Table I) injection of A
spleen cells into non-tumour-bearing mice
produced a GvHR (mean spleen index
2.33), which was significantly reduced
in the presence of a tumour transplant
(mean index 1-40). At the same time in-
jection of A spleen cells into tumour-
bearing F1 mice reduced the weight of
the tumour as recorded 10 days later
(median value 0-85 g), in comparison with
that in tumour-bearing mice not receiving
parent-line cells (median value 1 *44 g;
P< 0 05 Rank-sum test).
In Expt 2 injection of parent-line cells
did not significantly reduce tumour
weights on Day 8 thereafter. In parallel
with this observation, the presence of
a tumour did not reduce the level ofGvHR
following injection of parent-line cells
(Tahle I).
In Expt 3, as in Expt 1, the presence
of a tumour significantly reduced the
magnitude of the GvHR, and tumour
resection abolished this effect (Table I).
Injection of parent-line cells also led to a
significant reduction in tumour weight
(median values 0-87 g for mice receiving
cells vs 2-10 g for control tumours, P=
0.025).
OCT is found only in the mitochondria
ofhepatocytes (Vassef, 1978). This enzyme
is liberated by damage to the appropriate
cells, as reflected by a rise in its plasma
TABLE I.-The spleen indices of (A x CBA)F1 mice 8-10 days after injection of 108A
(immune to F1 tumour) spleen cells. An F1 tumour was transplanted into 2 groups of
recipient mice 20 days before injection ofparent-line cells, and in one of these groups
the tumour was resected the day before the spleen cells were given
Mean spleen index + s.e.
I
Groupt
A spleen cells
Tumour +A spleen cells
Tumour resected +
A spleen cells
Expt 1
2-33+0-06
P* Expt 2
1 93 + 0*15
<0-001
1*40+ 0*06 2-00+ 0*15
<0*001 NS
2-09+0-06 1-78<0-15
P Expt 3
2 *40+0-08
NS
1*73+0-08
2 -16±0 08
* By analysis of variance.
t Five to six animals/group.
21
p
<0-001
<0-001
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TABLE II.-Expts 4 an(i 5. The plasma levels of OCT in nice receiviny 2.5 jg of LPS,
24 h before beinyr killed on Day 28.
IPlasma OCT (iu/1) + s.e.
Grouipt Expt 4 Expt a
No treatment (no LPS) 4-94+ I 56 4-04+ I 7()
LPS (no tumour) 11*86+1*56*** 4 84+1*70
Fl tumour on Day 0 869+191 4-79+1 70
Fl tumour resected oni Day 20 NI) 3 14_ 1 .59
A spleen cells+ (no LPS) NI) 4*26+ 1 83
A spleencells 1365+ 2.2* 0*** 1031±.+ 159**
F1 tumour +A spleen (ells 391 +2*20 5a50+ 1*83
F1 ttumouir resected+A spleeIn cells 14 75+2 70*** 9-76+2 00*
I' from No tireatment, byT ainalvsis of variatnce * <0 05, ** <001, *** <0 005.
t 5-8 animals/group.
$ 108 i.v. injeetedi on D)av 21.
level. The plasma levels of OCT were
similar in all groups of mice not receiving
LPS in Expts 1 and 2. This is evidence
for a 2-stage process, in which GvHR
activates macrophages from which endo-
toxin then triggers lysosomal-enzyme re-
lease (Ferluga & Allison, 1978) writh
consequent damage to the surrounding
liver tissue.
After injection of LPS, the mice under-
going a GvHR due to injection of parent-
line cells, showed a significantly raised
OCT level in comparison with untreated
mice receiving no LPS (Expt 4, Table II).
This rise in OCT level was abolished when
the GvHR occurred in the presence of
a tumour, but the OCT level was again
significantly raised if the tumour was
resected 1 day before induction of GvHR.
On repeating this experiment (Expt 5,
Table II) in further groups of mice, in-
duction of GvHR was again associated
with a significant rise in OCT levels. This
was abrogated by the presence of a
tumour, but enzyme levels were again
increased if the tumour was resected.
A difference between Expts 4 and 5
was the effect of LPS injection on OCT
levels in normal mice. The OCT level was
raised in Expt 4 (Table II) which accords
with the finding of Bradfield et al. (1980)
but not in Expt 5 (Table II).
The increase in OCT levels in non-
tumour-bearing mice undergoing GvHR
indicated the sensitivityN of activated
liver macrophages to LPS challenge (Table
11).
It was not possible to measure spleen
weights and plasma-enzyme levels (after
LPS injection) in the same mice, as ad-
ministration of endotoxin caused a dra-
matic reduction in spleen weight, possibly
due to splenic contraction associated with
shock.
The presence of aI F'1 tumnour reduced
the magnitude of GvHR (as judged by the
spleen index) after injection of parent-
line cells into F1 mice, when, at the same
time, the spleen cells had a significant anti-
tumour action in terms of reduced tumour
weight. This finding accorded with that of
Whitmarsh-Everiss & Symes (1981). It
was also found that resection ofthe tumour
led t;o a restoration in the degree ofGvHR.
In both Expts 4 and 5, induction of
GvHR led to a significant rise in OCT,
suggesting the occurrence of liver damage
against which the host wAas protected by
the presence of a tumour, an effect
abolished by tumouir resection.
An F1 tumour may protect against
GvI-R by virtue of its antigenic mass
w%Ahich preoccupies the action ofthe parent-
line spleen cells (Whitmarsh-Everiss &
Symes, 1981). The reduction in tumour
size associated with protection against
GvHR accords with this idea. Also Whit-
marsh-Everiss & Symes (1981) showed that
an A-strain tumour growing in (A x CBA)
F1 mice, did not protect against GvHR
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by A spleen cells. In this genetic combina-
tion, the A spleen cells, being isogenic
with the tumour, could not react with it,
and accordingly the tumour size was not
reduced in animals undergoing GvHR.
An alternative or additional mechanism
by which a tumour acts is suggested by
the work of Cheung et al. (1979) who
found that tumour-derived products can
inhibit induction of macrophage tumorici-
dal activity by LPS. Other studies have
also shown that tumours produce a low-
mol-wt factor capable of inhibiting the
spreading adhesion and migration of
macrophages (Cantarow et al., 1978;
Fauve & Hevin, 1977) macrophage chemo-
taxis in vitro (Snyderman & Pike, 1976;
Nelson & Nelson, 1978) macrophage-
mediated resistance to Listeria infection
(North et al., 1976) and the early phase of
delayed-type hypersensitivity reaction to
SRBC in vivo (Nelson & Nelson, 1978).
Thus in the present study, tumour prod-
ucts may inhibit the release by LPS of
enzymes from macrophages activated by
GvHR.
The idea that a tumour may deflect
the immune response of foreign cells to
itself with consequent protection of the
host against GvHR, may stimulate
attempts to treat neoplasms by adoptive
transfer of immunologically competent
cells.
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